AstraZeneca plc (AZN) Ordinary US$0.25
20.00p
(0.18%)
- Add to watchlist
- Create an alert
- This stock can be held in a
20.00p
(0.18%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
20.00p
(0.18%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
10,866.00p
10,990.33p
11,288.00p
£168.31 bn
10,842.00p
10,748.00p
8,029.00p
1,635.94
128.00p (1.19%) Previous:
128.00p
452,561
1.93%
200
Performance
| 1 week 1W | 0.58% | 1 year 1Y | 32.3% |
|---|---|---|---|
| 1 month 1M | 2.13% | 2 years 2Y | 28% |
| 3 months 3M | 8.14% | 3 years 3Y | 50.02% |
| 6 months 6M | 25.34% | 5 years 5Y | 140.61% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2021 | 31/12/2020 |
|---|---|---|
| Revenue ($m) | 37.42 | 26.62 |
| Profit before tax ($m) | (0.27) | 3.92 |
| Adjusted EPS (¢): | 8.00 | 244.00 |
| P/E ratio | 1,310.70 | 36.30 |
| PEG | n/a | 0.30 |
| EPS growth (%) | (97.00) | 137.00 |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by AstraZeneca plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| 1st interim * | 11/08/2022 | 12/09/2022 | 93.00¢ |
| 2nd interim | 24/02/2022 | 28/03/2022 | 197.00¢ |
| 1st interim | 12/08/2021 | 13/09/2021 | 90.00¢ |
| 2nd interim | 25/02/2021 | 29/03/2021 | 190.00¢ |
| 1st interim | 13/08/2020 | 14/09/2020 | 90.00¢ |
* Dividend has not yet been paid but has been declared by AstraZeneca plc.
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual AstraZeneca plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2021 | 2.70% | 0.03 | $2.87 |
| 31/12/2020 | 3.20% | 0.87 | $2.80 |
| 31/12/2019 | 3.00% | 0.37 | $2.80 |
| 31/12/2018 | 3.90% | 0.61 | $2.80 |
| 31/12/2017 | 4.50% | 1.53 | $2.80 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
AstraZeneca gets US approval for breast cancer treatment
8 August 2022 09:49
-
AstraZeneca breast cancer drug receives EU approval
4 August 2022 08:52
-
ShoreCap stays at 'buy' on AstraZeneca, sees further upgrades ahead on product pipeline
29 July 2022 12:45
-
Enhertu approved in the US for HER2-low mBC
8 August 2022 07:10
-
Lynparza approved in EU for early breast cancer
4 August 2022 07:00
-
Director/PDMR Shareholding
1 August 2022 17:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.